Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
3.160
+0.170 (5.69%)
At close: Oct 23, 2026, 4:00 PM EDT
3.180
+0.020 (0.63%)
After-hours: Oct 23, 2026, 7:30 PM EDT
Indaptus Therapeutics Market Cap
Indaptus Therapeutics has a market cap or net worth of $485.32 million as of October 23, 2026. It is the 14,726th most valuable company in the world and the 2,749th biggest in the United States. Its market cap has increased by 12,612.87% in one year.
Market Cap
485.32M
Enterprise Value
473.76M
1-Year Change
12,612.87%
Global Rank
Country Rank
#2,749 United States
Category
ChartMarket Cap Chart
Since August 4, 2021, Indaptus Therapeutics's market cap has increased from $47.95M to $485.32M, an increase of 912.11%. That is a compound annual growth rate of 55.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 485.32M | 9,423.70% |
| Dec 31, 2025 | 5.10M | -49.63% |
| Dec 31, 2024 | 10.12M | -31.58% |
| Dec 29, 2023 | 14.79M | 21.38% |
| Dec 30, 2022 | 12.18M | -73.92% |
| Dec 31, 2021 | 46.70M | -2.60% |
| Aug 4, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ProKidney | 435.34M |
| Altimmune | 433.77M |
| Eikon Therapeutics | 433.32M |
| Autolus Therapeutics | 431.18M |
| Tectonic Therapeutic | 426.96M |
| Assembly Biosciences | 416.58M |
| ARS Pharmaceuticals | 415.69M |
| Prothena Corporation | 412.24M |